Nanostructured Lipid Carriers for Anticancer Drug Delivery: Bridging Preclinical Advances and the Bench-to-Clinic Translational Gap.
Nanostructured lipid carriers (NLCs) are known to improve the delivery of poorly soluble, unstable, rapidly cleared, or systemically toxic anticancer drugs. Their mixed solid- and liquid-lipid matrix can improve drug incorporation, reduce drug expulsion, and support controlled release. Despite encouraging findings across different cancer models, the important question of "Why the strong preclinical promise of NLCs has not yet been translated into clinical oncology?" remains. Unlike published reviews that mainly focus on formulation, characterization, individual administration routes, or tumor-targeting strategies, the current review examines NLC-based anticancer drug delivery from a broader bench-to-clinic translational gap perspective. Specifically, this review connects formulation design and preclinical performance with the practical barriers that influence clinical development of NLCs. Literature was retrieved from PubMed/MEDLINE, Scopus, Web of Science Core Collection, and Google Scholar. The literature search covered publications from 2008 to 2026. The key terms included "nanostructured lipid carrier" OR "nanostructured lipid carriers" OR "NLC" OR "NLCs" OR "solid lipid nanoparticle" OR "lipid nanocarrier" AND "cancer" OR "tumour" OR "tumour" OR "anticancer" OR "antitumor" OR "antitumour" OR "oncology" AND "drug delivery" OR "targeted delivery" OR "co-delivery" OR "pharmacokinetic". The review also evaluates its application in preclinical, clinical and patented NLCs for cancer treatment, which have received comparatively limited attention.
Authors
- Khairul Akmal Azhar
- Chin Siang Kue (ORCID: https://orcid.org/0000-0002-9793-5616)
- Anyanee Kamkaew (ORCID: https://orcid.org/0000-0003-1203-2686)
- Khairunnisa Nabilah Binti Mohamed Hussein
- Wardina Abdul Halim
Institutions
- Management and Science University (MY)
- University of Malaya (MY)
- Suranaree University of Technology (TH)
Publication Details
- Journal
- PubMed
- Published
- 2026-11-17
- DOI
- https://doi.org/10.2174/0113892010508566261112114605
- Primary Topic
- Advancements in Transdermal Drug Delivery
- Type
- article
- Field-Weighted Citation Impact
- 0.00